# La Clinica Tepeyac Inc

Health Center, CO
Page: https://astrelis.co/providers/health_center/061962  
This twin: https://astrelis.co/providers/health_center/061962.md  
CMS Certification Number (CCN): 061962  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2023)

- **Total patients (UDS) (FY2024):** 7,560. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total visits (all service types) (FY2024):** 31,838. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 3. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 54.9%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2022):** -368.6%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2022):** $1.6M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2022):** +18.3%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### LA CLINICA TEPEYAC, INC., CO

Match to this profile: identifier verified: the EIN the dataset carries for this CCN agrees with the filed EIN (method: exact name and state, narrowed by address (FACLAND tier 1+3)).

- FY ending 2025-12-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-12-GSAFAC-0000419848
- FY ending 2024-12-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000376382
- FY ending 2023-12-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000058324

| Line | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 7,543,632 [derived, p.6] | 2,801,975 [derived, p.6] | 3,000,964 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 518,090 [derived, p.6] | 594,970 [derived, p.6] | 403,263 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 2,172,209 [derived, p.6] | 1,177,495 [derived, p.6] | 1,131,993 [derived, p.6] |
| other current assets (Statement of financial position) | 62,955 [derived, p.6] | 109,367 [derived, p.6] | 112,804 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 10,296,886 [extracted, p.6] | 4,683,807 [extracted, p.6] | 4,649,024 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 16,346,395 [derived, p.6] | 16,710,034 [derived, p.6] | 16,985,513 [derived, p.6] |
| other long-term assets (Statement of financial position) | 10,440,339 [derived, p.6] | 9,555,324 [derived, p.6] | 9,706,897 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 37,083,620 [extracted, p.6] | 30,949,165 [extracted, p.6] | 31,341,434 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 457,568 [derived, p.6] | 679,203 [derived, p.6] | 1,257,543 [derived, p.6] |
| deferred revenue (Statement of financial position) | 200,000 [derived, p.6] | 492,276 [derived, p.6] | 132,592 [derived, p.6] |
| current debt and leases (Statement of financial position) | 75,352 [derived, p.6] | 73,934 [derived, p.6] | 88,197 [derived, p.6] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 732,920 [extracted, p.6] | 1,245,413 [extracted, p.6] | 1,478,332 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 20,518,542 [derived, p.6] | 20,404,102 [derived, p.6] | 20,289,478 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | 500,000 [derived, p.6] | 500,000 [derived, p.6] | 500,000 [derived, p.6] |
| TOTAL LIABILITIES (Statement of financial position) | 21,751,462 [extracted, p.6] | 22,149,515 [extracted, p.6] | 22,267,810 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 8,719,808 [derived, p.6] | 8,306,240 [derived, p.6] | 6,844,030 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | 6,612,350 [derived, p.6] | 493,410 [derived, p.6] | 2,229,594 [derived, p.6] |
| TOTAL NET ASSETS (Statement of financial position) | 15,332,158 [extracted, p.6] | 8,799,650 [extracted, p.6] | 9,073,624 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 7,021,464 [derived, p.7] | 5,038,214 [derived, p.7] | 2,426,181 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 5,009,539 [derived, p.7] | 5,383,412 [derived, p.7] | 3,252,388 [derived, p.7] |
| contributions (Statement of activities) | 1,180,590 [derived, p.7] | 1,235,439 [derived, p.7] | 2,497,768 [derived, p.7] |
| other revenue (Statement of activities) | 328,095 [derived, p.7] | 2,010,372 [derived, p.7] | 1,639,554 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 13,539,688 [extracted, p.7] | 13,667,437 [extracted, p.7] | 9,815,891 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 6,753,349 [derived, p.7] | 7,064,280 [derived, p.7] | 6,135,051 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 2,848,445 [derived, p.7] | 1,771,412 [derived, p.7] | 1,052,988 [derived, p.7] |
| purchased and professional services (Statement of activities) | 927,346 [derived, p.7] | 785,342 [derived, p.7] | 1,208,735 [derived, p.7] |
| occupancy (Statement of activities) | 536,053 [derived, p.7] | 456,391 [derived, p.7] | 425,534 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 686,836 [derived, p.7] | 657,452 [derived, p.7] | 527,375 [derived, p.7] |
| interest (Statement of activities) | 498,892 [derived, p.7] | 514,525 [derived, p.7] | 544,211 [derived, p.7] |
| other expenses (Statement of activities) | 955,253 [derived, p.7] | 1,097,957 [derived, p.7] | 753,850 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 13,206,174 [extracted, p.7] | 12,347,359 [extracted, p.7] | 10,647,744 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | 333,514 [extracted, p.7] | 1,320,078 [extracted, p.7] | -831,853 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | 6,198,994 [derived, p.8] | -1,594,052 [derived, p.8] | 870,686 [derived, p.8] |
| CHANGE IN NET ASSETS (Statement of activities) | 6,532,508 [extracted, p.8] | -273,974 [extracted, p.8] | 38,833 [extracted, p.8] |
| net assets, beginning (Statement of activities) | 8,799,650 [extracted, p.8] | 9,073,624 [extracted, p.8] | 9,034,791 [extracted, p.8] |
| net assets, end (Statement of activities) | 15,332,158 [extracted, p.8] | 8,799,650 [extracted, p.8] | 9,073,624 [extracted, p.8] |

| Ratio | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| Days cash on hand | 220 days [plausible] | 88 days [plausible] | 108 days [plausible] |
| Current ratio | 14.05x [plausible] | 3.76x [plausible] | 3.14x [plausible] |
| Operating margin | 2.5% [plausible] | 9.7% [plausible] | -8.5% [plausible] |
| Total margin | 48.2% [plausible] | -2.0% [plausible] | 0.4% [plausible] |
| Patient revenue share | 51.9% [plausible] | 36.9% [plausible] | 24.7% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 51.1% [plausible] | 57.2% [plausible] | 57.6% [plausible] |
| Days in patient receivables | 27 days [plausible] | 43 days [plausible] | 61 days [plausible] |
| Debt to net assets | 1.34x [plausible] | 2.33x [plausible] | 2.25x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (LA CLINICA TEPEYAC, INC.; FAC-11 template snapshot, SRC-FAC-001).

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "La Clinica Tepeyac Inc", https://astrelis.co/providers/health_center/061962, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.